Role of iron in neurodegenerative diseases.

Abstract

Currently, we still lack effective measures to modify disease progression in neurodegenerative diseases. Iron-containing proteins play an essential role in many fundamental biological processes in the central nervous system. In addition, iron is a redox-active ion and can induce oxidative stress in the cell. Although the causes and pathology hallmarks of different neurodegenerative diseases vary, iron dyshomeostasis, oxidative stress and mitochondrial injury constitute a common pathway to cell death in several neurodegenerative diseases. MRI is capable of depicting iron content in the brain, and serves as a potential biomarker for early and differential diagnosis, tracking disease progression and evaluating the effectiveness of neuroprotective therapy. Iron chelators have shown their efficacy against neurodegeneration in a series of animal models, and been applied in several clinical trials. In this review, we summarize recent developments on iron dyshomeostasis in Parkinson's disease, Alzheimer's disease, Friedreich ataxia, and Huntington's disease.

• Authors: Kai Li, Heinz Reichmann
• Journal: Journal of neural transmission (Vienna, Austria : 1996) (J Neural Transm (Vienna)) Vol. 123 Issue 4 Pg. 389-99 (Apr 2016) ISSN: 1435-1463 [Electronic] Austria
• PMID: 26794939 (Publication Type: Journal Article, Review)

Chemical References

• Iron

Topics

• Animals
• Humans
• Iron (metabolism)
• Neurodegenerative Diseases (metabolism)